Jeffery Kutok
Chief Scientific Officer, INFINITY PHARMACEUTICALS, INC.
Companies
- Epizyme, Inc.Chief Scientific Officer Apr 3, 2020 to Aug 16, 20221
- INFINITY PHARMACEUTICALS, INC.Chief Scientific Officer Feb 14, 2017 to Jan 13, 20202
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Epizyme, Inc.0 shares3Aug 12, 2022
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 12, 2022Returned to company 81,021 shares of Epizyme, Inc.3
- Aug 12, 2022Returned to company 39,046 shares of Epizyme, Inc.3
- Aug 9, 2022Shares withheld for tax 354,496 shares at $1.39 of Epizyme, Inc.4
- Aug 9, 2022Exercised options 380,000 shares at $1.39 of Epizyme, Inc.4
- Apr 11, 2022Sold 2,741 shares at $0.90 of Epizyme, Inc.5
- Feb 2, 2022Sold 2,556 shares at $1.37 of Epizyme, Inc.6
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Aug 11, 2022
- 5SEC EDGARForm 4 filed Apr 13, 2022
- 6SEC EDGARForm 4 filed Feb 4, 2022